Duke University Hospital Hematology and Medical Oncology

Topics

• Prostate Cancer Treatment and Research 460
• Hematopoietic Stem Cell Transplantation 431
• Cancer Immunotherapy and Biomarkers 333
• Multiple Myeloma Research and Treatments 325
• Hemoglobinopathies and Related Disorders 313
• Breast Cancer Treatment Studies 306
• Acute Myeloid Leukemia Research 290
• Childhood Cancer Survivors' Quality of Life 271
• Lymphoma Diagnosis and Treatment 257
• Palliative Care and End-of-Life Issues 254
• Pancreatic and Hepatic Oncology Research 248
• Chronic Lymphocytic Leukemia Research 226

Most cited

1. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms.

   Leukemia · 2022 · 3,300 citations · Sandeep S. Dave

2. Lobar or Sublobar Resection for Peripheral Stage IA Non-Small-Cell Lung Cancer.

   The New England journal of medicine · 2023 · 1,050 citations · Thomas Eldridge Stinchcombe

3. Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Expressing Solid Tumors: Primary Results From the DESTINY-PanTumor02 Phase II Trial.

   Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2024 · 935 citations · Soham Puvvada

4. Sequencing of 53,831 diverse genomes from the NHLBI TOPMed Program.

   Nature · 2021 · 1,859 citations · Marilyn Jo Telen

5. Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer.

   The New England journal of medicine · 2021 · 1,511 citations · Hope Elizabeth Uronis

6. Five-Year Survival Outcomes From the PACIFIC Trial: Durvalumab After Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer.

   Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2022 · 1,201 citations ·